References
- Kozak GP, Rowbotham JL. Diabetic foot disease: a major problem. In: Kozak GR Hoar CS, Rowbotham JL, et al, eds. Management of diabetic foot problems: Joslin Clinic and New England Deaconess Hospital. Philadelphia: WB Saunders, 1984: 1–8
- Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 1990: 13(5): 513–21
- Clements RS Jr, Bell DS. Diagnostic, pathogenetic, and therapeutic aspects of diabetic neuropathy. Special Topics Endocrinol Metab 1982: 3: 1–43
- Boulton AJ, Drury J, Clarke B, et al. Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care 1982: 5(4): 386–90
- Morley GK, Mooradian AD, Levine AS, et al. Mechanism of pain in diabetic peripheral neuropathy: effect of glucose on pain perception in humans. Am J Med 1984: 77(Jul): 79–82
- Corbin DO, Young RJ, Morrison DC, et al. Blood flow in the loot, polyneuropathy and foot ulceration in diabetes mellitus. Diabetologia 1987: 30(7): 468–73
- Watkins PJ, Edmonds ME. Sympathetic nerve failure in diabetes. Diabetologia 1983: 25(2): 73–7
- Louie TJ, Bartlett JG, Tally FP, et al. Aerobic and anaerobic bacteria in diabetic foot ulcers. Ann Intern Med 1976: 85(4): 461–3
- McIntyre KE. Control of infection in the diabetic foot: the role of microbiology, immunopathology, antibiotics, and guillotine amputation. J Vase Surg 1987: 5(5): 787–90
- Boulton AJ, Bowker JH, Gadia M, et al. Use of plaster casts in the management of diabetic neuropathic foot ulcers. Diabetes Care 1986: 9(2): 149–52
- Mueller MJ, Diamond JE, Sinacore DR, et al. Total contact casting in treatment of diabetic plantar ulcers: controlled clinical trial. Diabetes Care 1989: 12(6): 384–8
- Davidson JK. The Grady Memorial Hospital diabetes programme. In: Mann JI, Pyorala K, Teuscher A, eds. Diabetes in epidemiological perspective. New York: Longman (Churchill Livingstone), 1983: 332–41
- Miller LV, Goldstein J, Kumar D, et al. Assessment of program effectiveness at the Los Angeles County-University of Southern California Medical Center. In: Steiner G, Lawrence PA, eds. Educating diabetic patients. New York: Springer, 1981: 349–59
- Banga JD, Sixma JJ. Diabetes mellitus, vascular disease and thrombosis. Clin Haematol 1986: 15(2): 465–92
- LoGerfo FW, Coffman JD. Current concepts: vascular and microvascular disease of the foot in diabetes. Implications for foot care. N Engl J Med 1984: 311(25): 1615–9
- Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham Study. JAMA 1979: 241 (19): 2035–8
- Neubauer B, Christensen NJ, Christensen T, et al. Diabetic macroangiopathy: medial calcifications, narrowing, rugosities, stiffness, norepinephrine depletion and reduced blood flow capacity in the leg arteries. Acta Med Scand Suppl 1984: 687: 37–45
- Edmonds ME, Morrison N, Laws JW, et al. Medial arterial calcification and diabetic neuropathy. BMJ 1982: 284(27 Mar): 928–30
- Bell ET. Diabetes mellitus: a clinical and pathological study of 2,529 cases. Springfield, IL: CC Thomas, 1960 (American lecture series, No. 410)
- Strandness DE Jr, Priest RE, Gibbons GE. Combined clinical and pathologic study of diabetic and nondiabetic peripheral arterial disease. Diabetes 1964: 13(4): 366–72
- Goldenberg S, Alex M, Joshi RA, et al. Nonatheromatous peripheral vascular disease of the lower extremity in diabetes mellitus. Diabetes 1959: 8(4): 261–73
- Williamson JR, Kilo C. Vascular complications in diabetes mellitus. (Editorial) N Engl J Med 1980: 302(7): 399–400
- Moyer JH, Bell DS. Vasodilator drugs for peripheral vascular disturbances. In: Modell W, ed. Drugs of choice: 1980–1981. St Louis: Mosby-Year Book, 1980: 441–9
- Dornhorst A, Powell SH, Pensky J. Aggravation by propranolol of hyperglycaemic effect of hydrochlorothiazide in type II diabetics without alteration of insulin secretion. Lancet 1985: 1(8421): 123–6
- Popp DA, Tse TF, Shah SD, et al. Oral propranolol and metoprolol both impair glucose recovery from insulin-induced hypoglycemia in insulin- dependent diabetes mellitus. Diabetes Care 1984: 7(3): 243–7
- Roberts DH, Tsao Y, McLoughlin GA, et al. Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication. Lancet 1987: 2(8560): 650–3
- Juhan I, Vague P, Buonocore M, et al. Abnormalities of erythrocyte deformability and platelet aggregation in insulin-dependent diabetics corrected by insulin in vivo and in vitro. Lancet 1982: 1(8271): 535–7
- Baker DE, Campbell KR. Trental: a new drug for peripheral vascular disease. Pract Gastroenterol 1984: 8(Mar-Apr): 43–6
- Di Perri T, Guerrini M. Placebo controlled double blind study with pentoxifylline of walking performance in patients with intermittent claudication. Angiology 1983: 34(1): 40–5
- Roeren T, LeVeen RF, Nugent L. Photo-plethysmographic documentation of improved microcirculation after pentoxifylline therapy. Angiology 1988: 39(11): 929–33
- Brezis M, Epstein FH. A closer look at radio- contrast-induced nephropathy. (Editorial) N Engl J Med 1989: 320(3): 179–81
- Levin ME. Diabetic peripheral vascular disease. In: Rifkin, Raskin P, eds. Diabetes mellitus. Vol 5. Bowie, MD: Robert J. Brady, 1980: 281–9
- Gutman M, Kaplan O, Skornick Y, et al. Gangrene of the lower limbs in diabetic patients: a malignant complication. Am J Surg 1987: 154(3): 305–8